Subscribe to RSS
DOI: 10.1055/s-0033-1351125
Cost and Health Care Utilization in ARDS—Different from Other Critical Illness?
Publication History
Publication Date:
11 August 2013 (online)
Abstract
Costs of care in the intensive care unit are a frequent target for concern in the current health care system. Utilization of critical care services in the United States is increasing and will continue to do so. Acute respiratory distress syndrome (ARDS) is a common and important complication of critical illness. Patients with ARDS frequently have long hospitalizations and consume a significant amount of health care resources. Many patients are discharged with functional limitations and high susceptibility to new complications that require significant additional health care resources. There is increasing literature on the cost-effectiveness of the treatment of ARDS, and despite its high costs, treatment remains a cost-effective intervention by current societal standards. However, when ARDS leads to prolonged mechanical ventilation, treatment becomes less cost-effective. Current research seeks to find interventions that lead to reductions in duration of mechanical ventilation and intensive care unit (ICU) length of stay. Limited reductions in ICU length of stay have benefits for the patient, but they do not lead to significant reductions in overall hospital costs. Early discharge to post–acute care facilities can reduce hospital costs but are unlikely to decrease costs for an entire episode of illness. Improved effectiveness of communication between clinicians and patients or their surrogates could help avoid costly interventions with poor expected outcomes.
-
References
- 1 Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med 2010; 38 (1) 65-71
- 2 Rubenfeld GD, Caldwell E, Peabody E , et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353 (16) 1685-1693
- 3 Wunsch H, Linde-Zwirble WT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation use in the United States. Crit Care Med 2010; 38 (10) 1947-1953
- 4 Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005; 33 (6) 1266-1271
- 5 Jegers M, Edbrooke DL, Hibbert CL, Chalfin DB, Burchardi H. Definitions and methods of cost assessment: an intensivist's guide. ESICM section on health research and outcome working group on cost effectiveness. Intensive Care Med 2002; 28 (6) 680-685
- 6 Kahn JM. Understanding economic outcomes in critical care. Curr Opin Crit Care 2006; 12 (5) 399-404
- 7 Kahn JM, Rubenfeld GD, Rohrbach J, Fuchs BD. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. Med Care 2008; 46 (12) 1226-1233
- 8 Cox CE, Martinu T, Sathy SJ , et al. Expectations and outcomes of prolonged mechanical ventilation. Crit Care Med 2009; 37 (11) 2888-2894 , quiz 2904
- 9 Gold MR. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996
- 10 Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research. Am J Respir Crit Care Med 2002; 165 (4) 540-550
- 11 Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000; 20 (3) 332-342
- 12 Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 2003; 163 (14) 1637-1641
- 13 Braithwaite RS, Meltzer DO, King Jr JT, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?. Med Care 2008; 46 (4) 349-356
- 14 Cooper LM, Linde-Zwirble WT. Medicare intensive care unit use: analysis of incidence, cost, and payment. Crit Care Med 2004; 32 (11) 2247-2253
- 15 Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B CubRea. A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 2001; 27 (1) 146-153
- 16 Wunsch H, Guerra C, Barnato AE, Angus DC, Li G, Linde-Zwirble WT. Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA 2010; 303 (9) 849-856
- 17 Cooke CR, Kahn JM, Watkins TR, Hudson LD, Rubenfeld GD. Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 2009; 136 (1) 79-88
- 18 Cox CE, Carson SS, Govert JA, Chelluri L, Sanders GD. An economic evaluation of prolonged mechanical ventilation. Crit Care Med 2007; 35 (8) 1918-1927
- 19 Linko R, Suojaranta-Ylinen R, Karlsson S, Ruokonen E, Varpula T, Pettilä V. FINNALI study investigators. One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure. Crit Care 2010; 14 (2) R60
- 20 Hamel MB, Phillips RS, Davis RB , et al. Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med 2000; 109 (8) 614-620
- 21 Carson SS. Outcomes of prolonged mechanical ventilation. Curr Opin Crit Care 2006; 12 (5) 405-411
- 22 Cox CE, Carson SS, Lindquist JH, Olsen MK, Govert JA, Chelluri L. Quality of Life after Mechanical Ventilation in the Aged (QOL-MV) Investigators. Differences in one-year health outcomes and resource utilization by definition of prolonged mechanical ventilation: a prospective cohort study. Crit Care 2007; 11 (1) R9
- 23 Zilberberg MD, Luippold RS, Sulsky S, Shorr AF. Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States. Crit Care Med 2008; 36 (3) 724-730
- 24 Unroe M, Kahn JM, Carson SS , et al. One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study. Ann Intern Med 2010; 153 (3) 167-175
- 25 Herridge MS, Cheung AM, Tansey CM , et al; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348 (8) 683-693
- 26 Cheung AM, Tansey CM, Tomlinson G , et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 174 (5) 538-544
- 27 Herridge MS, Tansey CM, Matté A , et al; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364 (14) 1293-1304
- 28 Knaus WA, Harrell Jr FE, Lynn J , et al. The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995; 122 (3) 191-203
- 29 Jung KT, Shin DW, Lee KJ, Oh M. Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review. J Clin Neurol 2010; 6 (3) 117-126
- 30 Merchant RM, Becker LB, Abella BS, Asch DA, Groeneveld PW. Cost-effectiveness of therapeutic hypothermia after cardiac arrest. Circ Cardiovasc Qual Outcomes 2009; 2 (5) 421-428
- 31 Gorenoi V, Schönermark MP, Hagen A. Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris. GMS Health Technol Assess 2011; 7: Doc07
- 32 Noyes K, Veazie P, Hall WJ , et al. Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial. J Cardiovasc Electrophysiol 2013; 24 (1) 66-74
- 33 Lee KH, Angus DC, Abramson NS. Cardiopulmonary resuscitation: what cost to cheat death?. Crit Care Med 1996; 24 (12) 2046-2052
- 34 Rossi C, Simini B, Brazzi L , et al; Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva. Variable costs of ICU patients: a multicenter prospective study. Intensive Care Med 2006; 32 (4) 545-552
- 35 Carson SS, Cox CE, Holmes GM, Howard A, Carey TS. The changing epidemiology of mechanical ventilation: a population-based study. J Intensive Care Med 2006; 21 (3) 173-182
- 36 Shwartz M, Iezzoni LI, Moskowitz MA, Ash AS, Sawitz E. The importance of comorbidities in explaining differences in patient costs. Med Care 1996; 34 (8) 767-782
- 37 Lyon SM, Benson NM, Cooke CR, Iwashyna TJ, Ratcliffe SJ, Kahn JM. The effect of insurance status on mortality and procedural use in critically ill patients. Am J Respir Crit Care Med 2011; 184 (7) 809-815
- 38 Berenholtz SM, Pronovost PJ, Lipsett PA , et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32 (10) 2014-2020
- 39 Pronovost P, Needham D, Berenholtz S , et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355 (26) 2725-2732
- 40 Schwebel C, Lucet JC, Vesin A , et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med 2012; 40 (1) 11-17
- 41 Chalupka AN, Talmor D. The economics of sepsis. Crit Care Clin 2012; 28 (1) 57-76 , vi
- 42 Saleh SS, Callan M, Therriault M, Landor N. The cost impact of hospital-acquired conditions among critical care patients. Med Care 2010; 48 (6) 518-526
- 43 Kaushal R, Bates DW, Franz C, Soukup JR, Rothschild JM. Costs of adverse events in intensive care units. Crit Care Med 2007; 35 (11) 2479-2483
- 44 Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ. Long-term acute care hospital utilization after critical illness. JAMA 2010; 303 (22) 2253-2259
- 45 Hall WB, Willis LE, Medvedev S, Carson SS. The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay. Am J Respir Crit Care Med 2012; 185 (1) 53-57
- 46 Long-term care hospitals payment system. 2012. http://www.medpac.gov/documents/MedPAC_Payment_Basics_12_LTCH.pdf
- 47 Utilization and payment effects of Medicare referrals to long-term care hospitals. 2011. . http://www.rti.org/reports/cms/kennell/CMS_LTCH_Referral_Effects.pdf
- 48 Gasperino J. The Leapfrog initiative for intensive care unit physician staffing and its impact on intensive care unit performance: a narrative review. Health Policy 2011; 102 (2-3) 223-228
- 49 Ward NS, Afessa B, Kleinpell R , et al; Members of Society of Critical Care Medicine Taskforce on ICU Staffing. Intensivist/patient ratios in closed ICUs: a statement from the Society of Critical Care Medicine Taskforce on ICU Staffing. Crit Care Med 2013; 41 (2) 638-645
- 50 Moran J, Scanlon D. Slow progress on meeting hospital safety standards: learning from the Leapfrog Group's efforts. Health Aff (Millwood) 2013; 32 (1) 27-35
- 51 Wallace DJ, Angus DC, Barnato AE, Kramer AA, Kahn JM. Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med 2012; 366 (22) 2093-2101
- 52 Reriani M, Biehl M, Sloan JA, Malinchoc M, Gajic O. Effect of 24-hour mandatory vs on-demand critical care specialist presence on long-term survival and quality of life of critically ill patients in the intensive care unit of a teaching hospital. J Crit Care 2012; 27 (4) e1-e7
- 53 Zilberberg MD, de Wit M, Shorr AF. Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: update using 2000-2008 data. Crit Care Med 2012; 40 (1) 18-20
- 54 Guentner K, Hoffman LA, Happ MB , et al. Preferences for mechanical ventilation among survivors of prolonged mechanical ventilation and tracheostomy. Am J Crit Care 2006; 15 (1) 65-77
- 55 Nelson JE, Mercado AF, Camhi SL , et al. Communication about chronic critical illness. Arch Intern Med 2007; 167 (22) 2509-2515
- 56 Carson SS, Kahn JM, Hough CL , et al; ProVent Investigators. A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation. Crit Care Med 2012; 40 (4) 1171-1176
- 57 Talmor D, Greenberg D, Howell MD, Lisbon A, Novack V, Shapiro N. The costs and cost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med 2008; 36 (4) 1168-1174
- 58 Boudreau DM, Guzauskas G, Villa KF, Fagan SC, Veenstra DL. A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke. Ann Emerg Med 2013; 61 (1) 46-55
- 59 Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. University of Washington Medical Center Lung Transplant Study Group. The cost-effectiveness of lung transplantation. A pilot study. Chest 1995; 108 (6) 1594-1601